These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589 [TBL] [Abstract][Full Text] [Related]
10. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493 [TBL] [Abstract][Full Text] [Related]
11. AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease. Ivachtchenko AV; Lavrovsky Y; Ivanenkov YA Mol Pharm; 2016 Mar; 13(3):945-63. PubMed ID: 26886442 [TBL] [Abstract][Full Text] [Related]
12. AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models. Ivachtchenko AV; Ivanenkov YA; Veselov MS; Okun IM Curr Alzheimer Res; 2017; 14(3):268-294. PubMed ID: 27829340 [TBL] [Abstract][Full Text] [Related]
13. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease. Geldenhuys WJ; Van der Schyf CJ Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055 [TBL] [Abstract][Full Text] [Related]
14. Impact of the Substitution Pattern at the Basic Center and Geometry of the Amine Fragment on 5-HT Grychowska K; Pietruś W; Kulawik L; Bento O; Satała G; Bantreil X; Lamaty F; Bojarski AJ; Gołębiowska J; Nikiforuk A; Marin P; Chaumont-Dubel S; Kurczab R; Zajdel P Molecules; 2023 Jan; 28(3):. PubMed ID: 36770761 [TBL] [Abstract][Full Text] [Related]